Michael Egholm

CIK 1559779 · President & CEO · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.86M

Companies

3

Total Filings

40

Lifetime Open-Market Net

-$3.25M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LAB President & CEO 6,597,956 $0.89 $5.86M -$15.1K 20 2026-05-22
IsoPlexis Corp (ISO) Delisted Director $0.76 $0 1 2022-06-21
PALL CORP (PLL) Delisted President, BioPharmaceuticals 0 $7.25 $0 -$3.23M 19 2015-08-31

Recent Filings · Page 2 of 4

40 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-04-08 LAB Mixed +138,836 -$61.7K EDGAR
2025-03-24 LAB Grant (A) +1,188,333 $0 EDGAR
2025-02-24 LAB Tax (F) −31,031 -$43.1K EDGAR
2024-11-21 LAB Tax (F) −28,795 -$43.5K EDGAR
2024-09-05 LAB Tax (F) −29,093 -$55.6K EDGAR
2024-05-21 LAB Grant (A) +1,000,000 $0 EDGAR
2024-04-09 LAB Tax (F) −102,564 -$277.9K EDGAR
2024-04-05 LAB Mixed +417,644 $0 EDGAR
2023-04-06 LAB Exer (M) +196,512 $0 EDGAR
2022-06-21 IsoPlexis Corp (ISO) Delisted Grant (A) $0 EDGAR
Showing 1120 of 40
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.